Bank of New York Mellon Corp Sells 40,221 Shares of Azenta, Inc. (NASDAQ:AZTA)

Bank of New York Mellon Corp lessened its position in Azenta, Inc. (NASDAQ:AZTA - Free Report) by 9.2% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 395,746 shares of the company's stock after selling 40,221 shares during the period. Bank of New York Mellon Corp owned about 0.87% of Azenta worth $19,787,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently made changes to their positions in AZTA. Farther Finance Advisors LLC raised its holdings in shares of Azenta by 20.0% during the third quarter. Farther Finance Advisors LLC now owns 1,537 shares of the company's stock valued at $74,000 after purchasing an additional 256 shares during the last quarter. KBC Group NV raised its holdings in shares of Azenta by 48.5% during the fourth quarter. KBC Group NV now owns 2,137 shares of the company's stock valued at $107,000 after purchasing an additional 698 shares during the last quarter. Assenagon Asset Management S.A. purchased a new position in shares of Azenta during the fourth quarter valued at approximately $200,000. Aigen Investment Management LP purchased a new position in shares of Azenta during the third quarter valued at approximately $214,000. Finally, Empowered Funds LLC purchased a new position in shares of Azenta during the fourth quarter valued at approximately $293,000. Institutional investors own 99.08% of the company's stock.

Azenta Trading Down 4.3 %

AZTA stock traded down $1.64 during midday trading on Thursday, reaching $36.56. 951,894 shares of the company's stock traded hands, compared to its average volume of 587,274. Azenta, Inc. has a 52-week low of $35.88 and a 52-week high of $64.31. The stock has a market cap of $1.67 billion, a P/E ratio of -12.27 and a beta of 1.52. The stock's 50-day moving average is $48.70 and its 200 day moving average is $47.22.

Remove Ads

Azenta (NASDAQ:AZTA - Get Free Report) last announced its quarterly earnings data on Wednesday, February 5th. The company reported $0.08 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.05 by $0.03. Azenta had a negative net margin of 24.91% and a positive return on equity of 1.25%. As a group, research analysts expect that Azenta, Inc. will post 0.53 EPS for the current fiscal year.

Analysts Set New Price Targets

Several research analysts have recently weighed in on AZTA shares. TD Cowen raised shares of Azenta to a "hold" rating in a report on Thursday, February 27th. Stephens reaffirmed an "overweight" rating and set a $60.00 target price on shares of Azenta in a report on Thursday, January 2nd. Evercore ISI upped their target price on shares of Azenta from $50.00 to $52.00 and gave the company an "in-line" rating in a report on Thursday, February 6th. Finally, Needham & Company LLC upped their target price on shares of Azenta from $55.00 to $59.00 and gave the company a "buy" rating in a report on Thursday, February 6th. Three investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, Azenta currently has an average rating of "Hold" and an average target price of $58.75.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.